The strong earnings report and positive guidance from Procter & Gamble detail effectively managed costos, robust sales, and the success of new products. However, the impact of integration efforts related to Gillette acquisitions and mixed results in some segments temper the overall picture. The stock is likely to experience a modest positive impact in the short term. [1]